Time taken for development (years) Best case Worst case 0 1 2 3 4 0 2 4 5 6 7+ Design and development of IP/Patent IBSC and RCGM approved LNP-mRNA vaccine development & Preclinical studies Completion of Human clinical trials PCT and WIPO patent granted C D S C O/ DCGI review and Approval Establish GMP manufacturing facility Commercialization and market launch LNP-mRNA vaccine clinical trials PCT and WIPO patent filed Cost (US $ million) 0.2 0.5 1.5 0.02 2 Co s t 1 2.5 7.5 10
Sep’23-Oct’23 1 month Oct’23-Jan’24 3 months Feb ’24-May ’24 3 months Jun ’24-Jun’25 12 months July’25-Dec’25 6 months